|
|||||
|
|
The use of intermediate dose cytosine arabinoside (ID Ara-C) in the treatment of relapsing or refractory cases of acute myelogenous leukemia |
|
| Authors: | F Kawano Y Tejima H Tajima S Y Lee A Shiozaki R Nakai M Chyosa T Sawada Y Maeda T Mizokuni |
| Abstract: | |
| Keywords: | |